concept

AMYLOID-BETA PATHOLOGY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AMYLOID-BETA PATHOLOGY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

18Connections
0Hypotheses
2Analyses
2Outgoing
16Incoming
0Experiments
6Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameAMYLOID-BETA PATHOLOGY
Key Genes/ProteinsAPOE4

Pathway Diagram

graph TD
    AMYLOID_BETA_PATHOLOGY[AMYLOID-BETA PATHOLOGY]
    AMYLOID_BETA_PATHOLOGY -->|causes| Neuronal_Dystrophy[Neuronal Dystrophy]
    AMYLOID_BETA_PATHOLOGY -->|causes| Cognitive_Decline[Cognitive Decline]
    p_tau217[p-tau217] -.biomarker for.-> AMYLOID_BETA_PATHOLOGY
    APOE[APOE] -->|modulates| AMYLOID_BETA_PATHOLOGY
    APOE4[APOE4] -->|promotes| AMYLOID_BETA_PATHOLOGY
    Glymphatic_Dysfunction[Glymphatic Dysfunction] -->|precedes| AMYLOID_BETA_PATHOLOGY
    Lipid_metabolism[Lipid metabolism] -->|modulates| AMYLOID_BETA_PATHOLOGY
    sphingosine_1_phosphate[sphingosine-1-phosphate] -->|suppresses| AMYLOID_BETA_PATHOLOGY
    ABCA7[ABCA7] -->|modulates| AMYLOID_BETA_PATHOLOGY

Outgoing (2)

TargetRelationTypeStr
Cognitive Declinecausesphenotype0.85
Neuronal Dystrophycausesphenotype0.85

Incoming (16)

SourceRelationTypeStr
p-tau217biomarker_forprotein0.93
APOE4promotesprotein0.90
APPK612T Mutantassociated_withprotein0.90
APOEmodulatesgene0.90
Glymphatic Dysfunctionprecedesprocess0.88

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

Why have numerous phase 3 clinical trials failed despite advances in understandi

neurodegeneration | 2026-04-12 | 1 hypotheses Top: 0.566

Lipid raft composition changes in synaptic neurodegeneration

neurodegeneration | 2026-04-01 | 15 hypotheses Top: 0.852

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (6)

Multi-agent debates referencing this entity

Extended debate: CYP46A1 Overexpression Gene Therapy

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: Membrane Cholesterol Gradient Modulators

closed · Rounds: 4 · Score: 0.50 · 2026-04-27

Hypothesis debate: Selective Acid Sphingomyelinase Modulation Therapy

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

Hypothesis debate: CYP46A1 Overexpression Gene Therapy

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

Why have numerous phase 3 clinical trials failed despite advances in understandi

closed · Rounds: 5 · Score: 0.67 · 2026-04-12

Investigate how lipid raft composition (cholesterol metabolism, sphingolipids) c

closed · Rounds: 5 · Score: 0.93 · 2026-04-11

Related Research

Hypotheses and analyses mentioning AMYLOID-BETA PATHOLOGY in their description or question text

No additional research found